{
  "abstract": "The authors here present an investigation of a novel vascular conduit, the Symvess acellular tissue-engineered vessel, that recently received FDA approval for use in vascular injury.1",
  "authors": [
    {
      "affiliations": [
        "Division of Vascular and Endovascular Trauma Surgery, R Adams Cowley Shock Trauma Center, Baltimore, Maryland, USA"
      ],
      "name": "Rishi Kundi"
    }
  ],
  "title": "New challenger has entered the arena: bioengineered vascular conduit, autologous vein, and prosthetic graft in extremity vascular trauma",
  "uid": "6a39944c-2e59-5a0a-8f4c-78a132f7ed9b"
}